News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dyax Corp. (DYAX) To Participate In The 2014 Leerink Swann and Company Global Healthcare Conference


2/7/2014 6:37:19 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Dyax Corp. (NASDAQ:DYAX) announced today that executive management will participate in the 2014 Leerink Global Healthcare Conference being held February 12-13, 2014 at the Waldorf Astoria in New York City. On Wednesday, February 12 at 11:05AM (ET), Gustav Christensen, President and Chief Executive Officer, will participate in a fireside chat to discuss the Company’s key value drivers – the KALBITOR® (ecallantide) business, DX-2930 and the Licensing and Funded Research Portfolio.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES